Replies to post #107272 on Biotech Values

[DewDiligence]

Quiz answer:

I think that the…response-guided therapy in this study is based on negative HCV RNA at week 4 only.

Correct! In prior HCV trials that incorporated response-guided therapy, a patient had to have undetectable virus at week 4 and a later measurement (usually at week 10 or week 12) in order to qualify for a 24-week (rather than a 48-week) regimen.